Healthy Skepticism Library item: 535

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Menkes DB.
Hazardous drugs in developing countries.
BMJ 1997 Dec 13; 315:(7122):1557-8
http://bmj.bmjjournals.com/cgi/content/full/315/7122/1557

Abstract:

The international pharmaceutical market shows substantial regional differences in availability and promotion of drugs. In developing countries commercial interests may conflict with public health needs as a result of promotion of unsafe drugs, counterfeit drugs and the exports of inappropriate pharmaceuticals. The medical community has a role to play in the effort to achieve rational drug use.

Keywords:
*editorial MaLAM Health Action International HAI WHO counterfeit drugs drug exports developing countries consumer groups EVALUATION OF PROMOTION: COMPARISON BETWEEN DEVELOPING AND DEVELOPED COUNTRIES INFLUENCE OF PROMOTION: ACCESS TO ESSENTIAL DRUGS